Tvardi Therapeutics, Inc. (TVRD): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2025-03-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

9.38M

As of 2025-12-31

9.38M

As of 2026-06-30

2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	9.38M	+264.4%	2026-03-31, Balance as of period end
2024-12-31	2.57M	n/c	2026-03-31, Balance as of period end
2023-12-31	4.54M	n/c	2025-03-11, Balance as of period end
2022-12-31	53.80M	+0.6%	2024-03-06, Balance as of period end
2021-12-31	53.48M	+7.2%	2023-03-06, Balance as of period end
2020-12-31	49.87M	+6.7%	2022-03-01, Balance as of period end
2019-12-31	46.72M	+18.1%	2021-02-25, Balance as of period end
2018-12-31	39.55M	+21.1%	2020-02-27, Balance as of period end
2017-12-31	32.66M	+19.7%	2019-03-12, Balance as of period end
2016-12-31	27.30M	+0.2%	2018-03-15, Balance as of period end
2015-12-31	27.25M	+19.5%	2017-03-10, Balance as of period end
2014-12-31	22.80M	+431.7%	2016-03-11, Balance as of period end
2013-12-31	4.29M	n/a	2015-03-27, Balance as of period end